Wim Terpstra
- Hematology top 2%
- Multiple Myeloma Research and Treatments 9
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 6
- Internal Medicine top 5%
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Oncology top 10%
- Bone health and treatments 3
-
- RNA Interference and Gene Delivery 3
-
- Spine and Intervertebral Disc Pathology 3
-
- Palliative Care and End-of-Life Issues 3
- Co-authors
- Bob LöwenbergGerard WagemakerA. PrinsAnja LeyteMark van SchilfgaardeHugo Ten CateHenri M.H. SpronkMarijke C. Trappenburg
- Cited by
- HematologyInternal MedicineGenetics
- Partner nations
- NetherlandsUnited StatesItaly
In The Last Decade
Wim Terpstra
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Hematology 542
- Internal Medicine 115
- Genetics 183
- Oncology 276
- Immunology 161
Countries citing papers authored by Wim Terpstra
This map shows the geographic impact of Wim Terpstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Terpstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Terpstra more than expected).
Fields of papers citing papers by Wim Terpstra
This network shows the impact of papers produced by Wim Terpstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Terpstra. The network helps show where Wim Terpstra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wim Terpstra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2019 | 119 | |
| 4 | 2018 | 8 | |
| 5 | 2014 | 8 | |
| 6 | 2013 | 39 | |
| 7 | [Prevention of severe toxicity from capecitabine, 5-fluorouracil and tegafur by screening for DPD-deficiency]. | 2012 | 6 |
| 8 | 2011 | 38 | |
| 9 | 2010 | 90 | |
| 10 | 2010 | 32 | |
| 11 | 2009 | 3 | |
| 12 | 2009 | 108 | |
| 13 | 2001 | 30 | |
| 14 | 1999 | 11 | |
| 15 | 1998 | 7 | |
| 16 | 1997 | 33 | |
| 17 | 1997 | 30 | |
| 18 | 1996 | 60 | |
| 19 | 1992 | 38 | |
| 20 | 1988 | 35 |
About Wim Terpstra
Wim Terpstra is a scholar working on Hematology, Genetics and Oncology, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (6 papers), RNA Interference and Gene Delivery (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Spine and Intervertebral Disc Pathology (3 papers), Palliative Care and End-of-Life Issues (3 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Hematology (542 citations), Internal Medicine (115 citations) and Genetics (183 citations). Wim Terpstra has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Bob Löwenberg, Gerard Wagemaker, A. Prins, Anja Leyte, Mark van Schilfgaarde, Hugo Ten Cate, Henri M.H. Spronk, Marijke C. Trappenburg, RE Ploemacher and AW Wognum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.